Polycystic ovary syndrome as a cardiometabolic risk factor

Abstract

Introduction: Polycystic ovary syndrome (PCOS) is a common endocrine disorder, affecting up to 18% of women of reproductive age and up to 70% remains undiagnosed, depending on the population and the diagnostic criteria used. PCOS is characterized by oligo/anovulation, hyperandrogenism, and polycystic ovaries. Objective: To provide an overview of current information on PCOS and cardiometabolic risk factors. Methodology:  A literature review was conducted based on the search for scientific publications related to the subject. Results: women with PCOS are at increased risk of cardiometabolic disorders such as overweight, obesity, high body mass index, insulin resistance, glucose intolerance, diabetes mellitus 2, dyslipidemia, hypertension, cardiovascular disease, and metabolic syndrome. Conclusions: The presence of cardiometabolic risk factors in women with PCOS increases the baseline risk of suffering from cardiometabolic disease, one of the main causes of death in women, therefore, prevention, diagnosis and timely and adequate treatment is essential starting from the first level of health.